{"id":{"repo_id":"bradford","oai_identifier":"oai:bradscholars.brad.ac.uk:10454/20594"},"canonical_url":"https://search.dev.ndltd.org/etd/bradford/oai:bradscholars.brad.ac.uk:10454/20594","repository":{"repo_id":"bradford","name":"University of Bradford","base_url":"https://bradscholars.brad.ac.uk/oai/request"},"display":{"title":"Synthesis, Physicochemical And Biopharmaceutical Characterisation Of Pro-Antibiotic Esters; Free Bases Of Ciprofloxacin","abstract":"Physicochemical and biopharmaceutical properties of drugs play a crucial role in their performance in vivo, especially with respect to oral bioavailability. In the case of antibiotics, poor bioavailability can indirectly encourage antimicrobial resistance from pressure selection resulting from subtherapeutic dosing. This study was designed to synthesise esters of Ciprofloxacin, a model drug using alcohol co-formers (isopentanol, n-butanol and isobutanol) with a view to improving the physicochemical and biopharmaceutical properties of Ciprofloxacin. Three esters of ciprofloxacin were synthesised, i.e., isopentanoate (CIP), n-butanoate (CNB) and isobutanoate (CIB). The effect of esterification on the physicochemical and biopharmaceutical properties of Ciprofloxacin was investigated. Thus, the lipophilicity, solubility, permeability, metabolism and antimicrobial efficacies were studied. The extent of uptake of these esters into E. Coli and S. aureus compared to Ciprofloxacin was also studied. A significant increase in lipophilicity and permeability was noted in all esters, with the branch-chained esters (CIP and CIB) having higher lipophilicity than the straight-chain ester (CNB). Solubility also increased compared to the parent drug, and all esters were successfully bioconverted into the parent compound without loss of activity. Esterification of Ciprofloxacin with isopenatanol, n-butanol and isobutanol improved its physicochemical and biopharmaceutical properties.","abstract_html":"Physicochemical and biopharmaceutical properties of drugs play a crucial role in their performance in vivo, especially with respect to oral bioavailability. In the case of antibiotics, poor bioavailability can indirectly encourage antimicrobial resistance from pressure selection resulting from subtherapeutic dosing. This study was designed to synthesise esters of Ciprofloxacin, a model drug using alcohol co-formers (isopentanol, n-butanol and isobutanol) with a view to improving the physicochemical and biopharmaceutical properties of Ciprofloxacin. Three esters of ciprofloxacin were synthesised, i.e., isopentanoate (CIP), n-butanoate (CNB) and isobutanoate (CIB). The effect of esterification on the physicochemical and biopharmaceutical properties of Ciprofloxacin was investigated. Thus, the lipophilicity, solubility, permeability, metabolism and antimicrobial efficacies were studied. The extent of uptake of these esters into E. Coli and S. aureus compared to Ciprofloxacin was also studied. A significant increase in lipophilicity and permeability was noted in all esters, with the branch-chained esters (CIP and CIB) having higher lipophilicity than the straight-chain ester (CNB). Solubility also increased compared to the parent drug, and all esters were successfully bioconverted into the parent compound without loss of activity. Esterification of Ciprofloxacin with isopenatanol, n-butanol and isobutanol improved its physicochemical and biopharmaceutical properties.","abstract_has_math":false,"creators":["Achi, Ifunnaya P.K."],"institution":"University of Bradford","degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":["Paluch, Krzysztof J.","Sheldrake, Helen","Katsikogianni, Maria"],"committee_chairs":[],"committee_members":[],"year":null,"date_issued":"","date_published":null,"updated_at":"2026-07-24T01:13:10Z","subjects":["Antibiotic prodrugs","Ester prodrugs","Ciprofloxacin","Ciprofloxacin esters","Solubility","Permeability","Biopharmaceutical classification system"],"languages":["en"],"rights":["<a rel=\"license\" href=\"http://creativecommons.org/licenses/by-nc-nd/3.0/\"><img alt=\"Creative Commons License\" style=\"border-width:0\" src=\"http://i.creativecommons.org/l/by-nc-nd/3.0/88x31.png\" /></a><br />The University of Bradford theses are licenced under a <a rel=\"license\" href=\"http://creativecommons.org/licenses/by-nc-nd/3.0/\">Creative Commons Licence</a>."],"rights_urls":[],"identifier_entries":[]},"links":{"outbound_url":"https://bradscholars.brad.ac.uk/handle/10454/20594","outbound_label":"Repository record","outbound_source":"dc:identifier.uri"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["Paluch, Krzysztof J.","Sheldrake, Helen","Katsikogianni, Maria"]},{"key":"dc:creator","label":"Author","values":["Achi, Ifunnaya P.K."]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2025-10-01T14:00:02Z"]},{"key":"dc:date.available","label":"Dc Date Available","values":["2025-10-01T14:00:02Z"]},{"key":"dc:publisher.department","label":"Dc Publisher Department","values":["School of Pharmacy and Medical Sciences. Faculty of Life Sciences"]},{"key":"dc:publisher.institution","label":"Dc Publisher Institution","values":["University of Bradford"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"dc:type.qualificationlevel","label":"Dc Type Qualificationlevel","values":["doctoral"]},{"key":"dc:type.qualificationname","label":"Dc Type Qualificationname","values":["PhD"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Antibiotic prodrugs","Ester prodrugs","Ciprofloxacin","Ciprofloxacin esters","Solubility","Permeability","Biopharmaceutical classification system"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.iso","label":"Language (ISO)","values":["en"]},{"key":"dc:rights","label":"Dc Rights","values":["<a rel=\"license\" href=\"http://creativecommons.org/licenses/by-nc-nd/3.0/\"><img alt=\"Creative Commons License\" style=\"border-width:0\" src=\"http://i.creativecommons.org/l/by-nc-nd/3.0/88x31.png\" /></a><br />The University of Bradford theses are licenced under a <a rel=\"license\" href=\"http://creativecommons.org/licenses/by-nc-nd/3.0/\">Creative Commons Licence</a>."]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://bradscholars.brad.ac.uk/handle/10454/20594"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Physicochemical and biopharmaceutical properties of drugs play a crucial role in their performance in vivo, especially with respect to oral bioavailability. In the case of antibiotics, poor bioavailability can indirectly encourage antimicrobial resistance from pressure selection resulting from subtherapeutic dosing. This study was designed to synthesise esters of Ciprofloxacin, a model drug using alcohol co-formers (isopentanol, n-butanol and isobutanol) with a view to improving the physicochemical and biopharmaceutical properties of Ciprofloxacin. Three esters of ciprofloxacin were synthesised, i.e., isopentanoate (CIP), n-butanoate (CNB) and isobutanoate (CIB). The effect of esterification on the physicochemical and biopharmaceutical properties of Ciprofloxacin was investigated. Thus, the lipophilicity, solubility, permeability, metabolism and antimicrobial efficacies were studied. The extent of uptake of these esters into E. Coli and S. aureus compared to Ciprofloxacin was also studied. A significant increase in lipophilicity and permeability was noted in all esters, with the branch-chained esters (CIP and CIB) having higher lipophilicity than the straight-chain ester (CNB). Solubility also increased compared to the parent drug, and all esters were successfully bioconverted into the parent compound without loss of activity. Esterification of Ciprofloxacin with isopenatanol, n-butanol and isobutanol improved its physicochemical and biopharmaceutical properties."]},{"key":"dc:title","label":"Title","values":["Synthesis, Physicochemical And Biopharmaceutical Characterisation Of Pro-Antibiotic Esters; Free Bases Of Ciprofloxacin"]}]}],"canonical_facts":{"dc:contributor.advisor":["Paluch, Krzysztof J.","Sheldrake, Helen","Katsikogianni, Maria"],"dc:creator":["Achi, Ifunnaya P.K."],"dc:date.accessioned":["2025-10-01T14:00:02Z"],"dc:date.available":["2025-10-01T14:00:02Z"],"dc:description.abstract":["Physicochemical and biopharmaceutical properties of drugs play a crucial role in their performance in vivo, especially with respect to oral bioavailability. In the case of antibiotics, poor bioavailability can indirectly encourage antimicrobial resistance from pressure selection resulting from subtherapeutic dosing. This study was designed to synthesise esters of Ciprofloxacin, a model drug using alcohol co-formers (isopentanol, n-butanol and isobutanol) with a view to improving the physicochemical and biopharmaceutical properties of Ciprofloxacin. Three esters of ciprofloxacin were synthesised, i.e., isopentanoate (CIP), n-butanoate (CNB) and isobutanoate (CIB). The effect of esterification on the physicochemical and biopharmaceutical properties of Ciprofloxacin was investigated. Thus, the lipophilicity, solubility, permeability, metabolism and antimicrobial efficacies were studied. The extent of uptake of these esters into E. Coli and S. aureus compared to Ciprofloxacin was also studied. A significant increase in lipophilicity and permeability was noted in all esters, with the branch-chained esters (CIP and CIB) having higher lipophilicity than the straight-chain ester (CNB). Solubility also increased compared to the parent drug, and all esters were successfully bioconverted into the parent compound without loss of activity. Esterification of Ciprofloxacin with isopenatanol, n-butanol and isobutanol improved its physicochemical and biopharmaceutical properties."],"dc:identifier.uri":["https://bradscholars.brad.ac.uk/handle/10454/20594"],"dc:language.iso":["en"],"dc:publisher.department":["School of Pharmacy and Medical Sciences. Faculty of Life Sciences"],"dc:publisher.institution":["University of Bradford"],"dc:rights":["<a rel=\"license\" href=\"http://creativecommons.org/licenses/by-nc-nd/3.0/\"><img alt=\"Creative Commons License\" style=\"border-width:0\" src=\"http://i.creativecommons.org/l/by-nc-nd/3.0/88x31.png\" /></a><br />The University of Bradford theses are licenced under a <a rel=\"license\" href=\"http://creativecommons.org/licenses/by-nc-nd/3.0/\">Creative Commons Licence</a>."],"dc:subject":["Antibiotic prodrugs","Ester prodrugs","Ciprofloxacin","Ciprofloxacin esters","Solubility","Permeability","Biopharmaceutical classification system"],"dc:title":["Synthesis, Physicochemical And Biopharmaceutical Characterisation Of Pro-Antibiotic Esters; Free Bases Of Ciprofloxacin"],"dc:type":["Thesis"],"dc:type.qualificationlevel":["doctoral"],"dc:type.qualificationname":["PhD"]},"updated_at":"2026-07-24T01:13:10Z"}